![Apogee Therapeutics Inc](/common/images/company/N_APGE.png)
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subc... Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts. Show more
NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical...
SAN FRANCISCO and WALTHAM, Mass., May 28, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing differentiated biologics for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 2.35 | 4.93697478992 | 47.6 | 52.08 | 45.7 | 320862 | 48.9703718 | CS |
4 | 10.65 | 27.0992366412 | 39.3 | 52.4 | 36.6 | 449809 | 44.77404018 | CS |
12 | -3.84 | -7.13887339654 | 53.79 | 56.1 | 36.26 | 449991 | 45.30700604 | CS |
26 | 13.44 | 36.8118323747 | 36.51 | 72.29 | 32.78 | 571634 | 52.1934086 | CS |
52 | 29.44 | 143.539736714 | 20.51 | 72.29 | 14.19 | 440737 | 41.43795397 | CS |
156 | 28.45 | 132.325581395 | 21.5 | 72.29 | 14.19 | 444708 | 40.63016164 | CS |
260 | 28.45 | 132.325581395 | 21.5 | 72.29 | 14.19 | 444708 | 40.63016164 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.